Sage Journals: Discover world-class research

Abstract

Background

Determining the growth rate of pancreatic cystic lesions on follow-up imaging is important in managing patients with these lesions. However, the growth rates of serous pancreatic neoplasms (SPNs) have been reported to vary among studies.

Purpose

To determine the in vivo growth rate of SPNs.

Material and Methods

This retrospective, single-institutional study included patients diagnosed with SPNs during 2006–2015. The diagnosis of SPNs was based on the results of surgery, endoscopic ultrasonography (EUS)-guided fine needle aspiration (FNA) or core needle biopsy (CNB), or typical radiologic features of SPN. A linear mixed-effects model was utilized to determine whether the diagnostic intervention was associated with tumor growth rate in all patients. The in vivo growth rate of SPNs was estimated from patients without or before diagnostic intervention. SPN growth rates were compared before and after diagnostic intervention.

Results

SPN growth rates in the overall patient cohort (n = 304) differed significantly between patients who did and did not undergo diagnostic interventions. The in vivo SPN growth rate in 204 patients without or before diagnostic intervention was 1.9 mm/year (95% confidence interval [CI] = 1.6–2.2). In the 130 patients who underwent diagnostic intervention, the SPN growth rate was significantly greater before than after diagnostic intervention (1.8 vs. 0.2 mm/year).

Conclusions

In the absence of diagnostic intervention, the in vivo growth rate of SPNs was 1.9 mm/year (95% CI = 1.6–2.2). EUS-guided FNA or CNB may affect the growth rate of SPNs.

Keywords

Serous pancreatic neoplasm serous cystic neoplasm serous cystadenoma pancreas growth rate CT

Get full access to this article

View all access options for this article.

References

Laffan

Horton

Klein

et al.

Prevalence of unsuspected pancreatic cysts on MDCT. Am J Roentgenol 2008; 191: 802–807.

Zhang

Mitchell

Dohke

et al.

Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology 2002; 223: 547–553.

Valsangkar

Morales-Oyarvide

Thayer

et al.

851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery 2012; 152: S4–12.

Kosmahl

Pauser

Peters

et al.

Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch 2004; 445: 168–178.

Dietrich

Dong

Jenssen

et al.

Serous pancreatic neoplasia, data and review. World J Gastroenterol 2017; 23: 5567–5578.

Tanaka

Fernandez-Del Castillo

Kamisawa

et al.

Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017; 17: 738–753.

Megibow

Baker

Morgan

et al.

Management of incidental pancreatic cysts: a white paper of the ACR Incidental Findings Committee. J Am Coll Radiol 2017; 14: 911–923.

Tanaka

Fernandez-del Castillo

Adsay

et al.

International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12: 183–197.

Kwong

Lawson

Hunt

et al.

Rapid growth rates of suspected pancreatic cyst branch duct intraductal papillary mucinous neoplasms predict malignancy. Dig Dis Sci 2015; 60: 2800–2806.

10.

Kang

Jang

Kim

et al.

Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol 2011; 9: 87–93.

11.

Allen

D'Angelica

Gonen

et al.

A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg 2006; 244: 572–582.

12.

Fukasawa

Maguchi

Takahashi

et al.

Clinical features and natural history of serous cystic neoplasm of the pancreas. Pancreatology 2010; 10: 695–701.

13.

Jais

Rebours

Malleo

et al.

Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut 2016; 65: 305–312.

14.

Malleo

Bassi

Rossini

et al.

Growth pattern of serous cystic neoplasms of the pancreas: observational study with long-term magnetic resonance surveillance and recommendations for treatment. Gut 2012; 61: 746–751.

15.

Tseng

Warshaw

Sahani

et al.

Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg 2005; 242: 413–419; discussion 419–421.

16.

Hammel

Levy

Voitot

et al.

Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology 1995; 108: 1230–1235.

17.

Kimura

Moriya

Hirai

et al.

Multicenter study of serous cystic neoplasm of the Japan pancreas society. Pancreas 2012; 41: 380–387.

18.

Akaike

Information theory and an extension of the maximum likelihood principle. In: Parzen

Tanabe

Kitagawa

(eds). Selected papers of Hirotugu Akaike, New York, NY: Springer, 1998, pp. 199–213.

19.

Hwang

Kim

Kang

et al.

Serous cyst adenoma of the pancreas: appraisal of active surgical strategy before it causes problems. Surg Endosc 2012; 26: 1560–1565.

20.

Strobel

Z’graggen

Schmitz-Winnenthal

et al.

Risk of malignancy in serous cystic neoplasms of the pancreas. Digestion 2003; 68: 24–33.

21.

Del Chiaro

Verbeke

Salvia

et al.

European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis 2013; 45: 703–711.

22.

Khalid

Brugge

. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol 2007; 102: 2339–2349.

23.

Buscarini

et al.

Italian Association of Hospital Gastroenterologists and Endoscopists, Italian Association for the Study of the Pancrease. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis 2014; 46: 479–493.

24.

Macari

Lee

Kim

et al.

Is gadolinium necessary for MRI follow-up evaluation of cystic lesions in the pancreas? Preliminary results. Am J Roentgenol 2009; 192: 159–164.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.12 MB

Growth rate of serous pancreatic neoplasms in vivo: a retrospective,observational study

Abstract

Background

Purpose

Material and Methods

Results

Conclusions

Keywords

Get full access to this article

References

Supplementary Material